MARKET

AYTU

AYTU

Aytu Biopharma Inc
NASDAQ
2.190
+0.060
+2.82%
After Hours: 2.190 0 0.00% 16:10 05/22 EDT
OPEN
2.135
PREV CLOSE
2.130
HIGH
2.190
LOW
2.120
VOLUME
20.56K
TURNOVER
--
52 WEEK HIGH
3.065
52 WEEK LOW
1.460
MARKET CAP
23.51M
P/E (TTM)
-0.4967
1D
5D
1M
3M
1Y
5Y
1D
Aytu BioScience Bets on EXXUA Amid Legacy Declines
TipRanks · 4d ago
Aytu BioPharma to present at Lytham Partners Spring Investor Conference
PUBT · 6d ago
Weekly Report: what happened at AYTU last week (0511-0515)?
Weekly Report · 6d ago
Aytu BioScience (AYTU) Gets a Buy from Maxim Group
TipRanks · 05/15 13:28
Aytu BioScience Earnings Call: EXXUA Drives Transition
TipRanks · 05/15 00:31
Lake Street Sticks to Its Buy Rating for Aytu BioScience (AYTU)
TipRanks · 05/14 13:21
Analysts Offer Insights on Healthcare Companies: Assertio Therapeutics (ASRT), Aytu BioScience (AYTU) and Oruka Therapeutics (ORKA)
TipRanks · 05/14 13:21
Aytu outlines $6M-$7M quarterly sales and marketing spend range as EXXUA scripts rise to over 920 in April
Seeking Alpha · 05/14 01:31
More
About AYTU
Aytu BioPharma, Inc. is a pharmaceutical company focused on advancing medicines for complex central nervous system (CNS) diseases. Its business is focused on the launch of EXXUA and its prescription pharmaceutical products sold primarily through third-party wholesalers and pharmacies and which primarily consists of two product portfolios. Its Attention Deficit Hyperactivity Disorder (ADHD) portfolio consists of Adzenys XR-ODT (amphetamine) extended-release orally disintegrating tablets (Adzenys) , Cotempla XR-ODT, and METADATE CD, which are CNS stimulants indicated for the treatment of ADHD in patients. Its Pediatric portfolio consists of Karbinal ER (carbinoxamine maleate extended-release oral suspension), an extended-release first-generation antihistamine indicated to treat various allergic conditions including seasonal and perennial allergic rhinitis, vasomotor rhinitis, Poly-Vi-Flor, and Tri-Vi-Flor. EXXUA is indicated to treat depressive disorder (MDD) in adults.

Webull offers Aytu Biopharma Inc stock information, including NASDAQ: AYTU real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AYTU stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading AYTU stock methods without spending real money on the virtual paper trading platform.